Aktis Oncology

unknown

Stage

About

Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers.

Explore Aktis Oncology's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.